Silicon Prairie News
Goldenrod Therapeutics raises $6.5 million to test UNMC-created drug that could change modern medicine
Incubated by Houston-based Fannin Innovation Studio, the 11h drug created in Nebraska will move toward phase 1 clinical trials in humans. If successful, it could serve as a miracle treatment for…
Read the original at Silicon Prairie NewsMore audio from Silicon Prairie News
-
5mPrairie Portraits: Taylor Korensky
The Prairie Portraits series features founders, funders and community builders from Nebraska's innovation and entrepreneurship ecosystem.
-
4mPrairie Portraits: Kristin Klaus
The Prairie Portraits series features founders, funders and community builders from Nebraska's innovation and entrepreneurship ecosystem.
-
5mPrairie Portraits: Corrine Wardian
The Prairie Portraits series features founders, funders and community builders from Nebraska's innovation and entrepreneurship ecosystem.
-
4mTech Nebraska to spin out from Nebraska Chamber and go independent on Sept. 1
The statewide tech association and lobbying organization was started in partnership with the Nebraska Chamber of Commerce & Industry. Now, it will pursue growth in tech advocacy and membership with an independent voice while still working with the chamber on common causes.
-
6mLincoln widens its gap from Omaha in the latest Best of the Midwest Startup Ecosystem Rankings
Midwest Startups presented by M25 released its annual rankings of 64 cities across the region. This marks the 10th year of Midwest Startups calculating a list to help founders, venture capitalists and community leaders identify the strengths and weaknesses of startup hubs. Omaha ranked 16th, and Lincoln ranked 13th.